You are currently viewing a new version of our website. To view the old version click .

Breast Cancer: From Pathophysiology to Therapeutic Strategies

This special issue belongs to the section “Cancer Biology and Oncology“.

Special Issue Information

Dear Colleagues,

This Special Issue, “Breast Cancer: Pathophysiology and Therapeutic Strategies”, will focus on the pathophysiology of breast cancer, new prognostic and/or predictive biomarkers of breast cancer, and novel therapeutic approaches for this disease.

Breast cancer is the most common cancer among women in the United States and around the world. The pathophysiology of breast cancer is complex, and numerous factors in a tumor and its microenvironment coordinately contribute to its progression and aggressiveness. Use of biomarkers has advanced breast cancer diagnosis and prognosis and prediction of therapeutic response. Identification of biomarkers has also advanced the development of targeted therapies for breast cancer. Novel therapeutic approaches and drug delivery systems have shown a promising beneficial effect in preclinical or clinical settings by affecting tumorigenesis, metastasis, and tumor–microenvironment interactions.

This Special Issue is open for basic and translational research and invites original articles and reviews on the following topics:

  • Pathophysiology;
  • Biomarkers;
  • New therapeutic approaches;
  • Drug delivery systems;
  • Immuno-oncology and the tumor microenvironment.

Dr. Xuemei Xie
Dr. Toshiaki Iwase
Dr. Jangsoon Lee
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • breast cancer
  • pathophysiology
  • biomarker
  • therapeutic approach
  • tumor microenvironment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059